APA (7th ed.) Citation

Deng, D., Zhu, H., Liu, Y., Chang, Y., Ruan, G., Jia, J., . . . Huang, X. (2019). Minimal residual disease detected by multiparameter flow cytometry is complementary to genetics for risk stratification treatment in acute myeloid leukemia with biallelic CEBPA mutations. Leukemia & Lymphoma, 60(9), 2181. https://doi.org/10.1080/10428194.2019.1576868

Chicago Style (17th ed.) Citation

Deng, Dao-Xing, et al. "Minimal Residual Disease Detected by Multiparameter Flow Cytometry Is Complementary to Genetics for Risk Stratification Treatment in Acute Myeloid Leukemia with Biallelic CEBPA Mutations." Leukemia & Lymphoma 60, no. 9 (2019): 2181. https://doi.org/10.1080/10428194.2019.1576868.

MLA (9th ed.) Citation

Deng, Dao-Xing, et al. "Minimal Residual Disease Detected by Multiparameter Flow Cytometry Is Complementary to Genetics for Risk Stratification Treatment in Acute Myeloid Leukemia with Biallelic CEBPA Mutations." Leukemia & Lymphoma, vol. 60, no. 9, 2019, p. 2181, https://doi.org/10.1080/10428194.2019.1576868.